Intended for healthcare professionals

  1. Research
  2. Safety related label...
  3. Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
CCBYNC Open access
Research

Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3837 (Published 07 September 2017) Cite this as: BMJ 2017;358:j3837

Related articles

BMJ opinionSpeed vs safety in the FDA’s new drug approvals—speed wins, again

See more

Cited by...

Back to top